For: | Kanda T, Ogasawara S, Chiba T, Haga Y, Omata M, Yokosuka O. Current management of patients with hepatocellular carcinoma. World J Hepatol 2015; 7(15): 1913-1920 [PMID: 26244066 DOI: 10.4254/wjh.v7.i15.1913] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v7/i15/1913.htm |
Number | Citing Articles |
1 |
Cheng Chen, Xiaoting Duan, Yanfeng Shen, Guiying Li. The clinical efficacy and safety of TACE combined with apatinib for advanced hepatocellular carcinoma: A propensity score matching analysis. Indian Journal of Cancer 2024; 61(2): 390 doi: 10.4103/ijc.IJC_967_20
|
2 |
Kun Liu, Yuening Zhang, Chengdong Zhang, Qinle Zhang, Jiatong Li, Feifan Xiao, Yingfang Li, Ruoheng Zhang, Dongwei Dou, Jiezhen Liang, Jian Qin, Zhidi Lin, Dong Zhao, Min Jiang, Zhenxin Liang, Jie Su, Vanaparthy Pranay Gupta, Min He, Xiaoli Yang. Methylation of S100A8 is a promising diagnosis and prognostic marker in hepatocellular carcinoma. Oncotarget 2016; 7(35): 56798 doi: 10.18632/oncotarget.10792
|
3 |
Long-Bin Jeng, Tsai-Chung Li, Wen-Ling Chan, Chiao-Fang Teng. Combination of Hepatitis B Virus Pre-S2 Gene Deletion Mutation and Tumor-Node-Metastasis Stage Predicts Higher Hepatocellular Carcinoma Recurrence after Curative Surgical Resection. Biomedicines 2023; 11(3): 923 doi: 10.3390/biomedicines11030923
|
4 |
Zaiba S. Dawood, Zachary J. Brown, Laura Alaimo, Henrique A. Lima, Chanza Shaikh, Erryk S. Katayama, Muhammad M. Munir, Zorays Moazzam, Yutaka Endo, Selamawit Woldesenbet, Timothy M. Pawlik. Comparison of tumor response and outcomes of patients with hepatocellular carcinoma after multimodal treatment including immune checkpoint inhibitors – a systematic review and meta-analysis. HPB 2024; 26(5): 618 doi: 10.1016/j.hpb.2024.02.003
|
5 |
Vahid Babaei, Masoud Ghorbani, Nastaran Mohseni, Hojjat Afraid, Yassaman Saghaei, Shahram Teimourian. Clinical correlations between chronic hepatitis C infection and decreasing bone mass density after treatment with interferon-alpha. Asian Pacific Journal of Tropical Biomedicine 2017; 7(2): 161 doi: 10.1016/j.apjtb.2016.11.027
|
6 |
|
7 |
Wei Wang, Li-Ping Hao, Haizhu Song, Xiao-Yuan Chu, Rui Wang. The Potential Roles of Exosomal Non-Coding RNAs in Hepatocellular Carcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.790916
|
8 |
Xin Ge, Liansheng Gong. MiR-590-3p suppresses hepatocellular carcinoma growth by targeting TEAD1. Tumor Biology 2017; 39(3): 101042831769594 doi: 10.1177/1010428317695947
|
9 |
Roberto Mazzanti, Umberto Arena, Renato Tassi. Hepatocellular carcinoma: Where are we?. World Journal of Experimental Medicine 2016; 6(1): 21-36 doi: 10.5493/wjem.v6.i1.21
|
10 |
Yu-Chen Tseng, Kuo-Feng Hsu, Yu-Ching Chou, Cheng-Chih Hsieh, Tsai-Yuan Hsieh, Teng-Wei Chen, Chung-Bao Hsieh, Yu-Lueng Shih. Impact of Resection versus Radiofrequency Ablation on Medium-Sized Hepatocellular Carcinomas. Journal of Medical Sciences 2022; 42(1): 26 doi: 10.4103/jmedsci.jmedsci_366_20
|
11 |
Masayuki Yokoyama, Tetsuhiro Chiba, Yoh Zen, Motohiko Oshima, Yuko Kusakabe, Yoshiko Noguchi, Kaori Yuki, Shuhei Koide, Shiro Tara, Atsunori Saraya, Kazumasa Aoyama, Naoya Mimura, Satoru Miyagi, Masanori Inoue, Toru Wakamatsu, Tomoko Saito, Sadahisa Ogasawara, Eiichiro Suzuki, Yoshihiko Ooka, Akinobu Tawada, Masayuki Otsuka, Masaru Miyazaki, Osamu Yokosuka, Atsushi Iwama. Histone lysine methyltransferase G9a is a novel epigenetic target for the treatment of hepatocellular carcinoma. Oncotarget 2017; 8(13): 21315 doi: 10.18632/oncotarget.15528
|
12 |
Chandramohan Kiruthiga, Kasi Pandima Devi, Seyed M. Nabavi, Anupam Bishayee. Autophagy: A Potential Therapeutic Target of Polyphenols in Hepatocellular Carcinoma. Cancers 2020; 12(3): 562 doi: 10.3390/cancers12030562
|
13 |
Atsushi Kobayashi, Toshimi Kaido, Yuhei Hamaguchi, Shinya Okumura, Kojiro Taura, Etsuro Hatano, Hideaki Okajima, Shinji Uemoto. Impact of postoperative changes in sarcopenic factors on outcomes after hepatectomy for hepatocellular carcinoma. Journal of Hepato-Biliary-Pancreatic Sciences 2016; 23(1): 57 doi: 10.1002/jhbp.302
|
14 |
L.A. Caicedo, A. Delgado, M. Duque, D.F. Jiménez, M. Sepulveda, J.A. García, L.S. Thomas, V.H. Garcia, A.M. Aristizabal, C. Gomez, A.M. Arrunategui, E. Manzi, M. Millan, J.I. Villegas, O. Serrano, A. Holguín, G.J. Echeverri. Tumor Biology as Predictor of Mortality in Liver Transplantation for Hepatocellular Carcinoma. Transplantation Proceedings 2018; 50(2): 485 doi: 10.1016/j.transproceed.2017.11.040
|
15 |
Tatsuo Kanda, Koji Takahashi, Masato Nakamura, Shingo Nakamoto, Shuang Wu, Yuki Haga, Reina Sasaki, Xia Jiang, Osamu Yokosuka. Androgen Receptor Could Be a Potential Therapeutic Target in Patients with Advanced Hepatocellular Carcinoma. Cancers 2017; 9(5): 43 doi: 10.3390/cancers9050043
|
16 |
Andrzej Krol, Barjor Gimi, Jo-Chi Jao, Ka-Wai Mac, Chiung-Yun Chang, Yu-Chiuan Wu, Chia-Chi Hsiao, Po-Chou Chen.
Monitoring of VX2 tumor growth in rabbit liver using T2-weighted and dynamic contrast-enhanced magnetic resonance imaging at 1.5T
. Medical Imaging 2017: Biomedical Applications in Molecular, Structural, and Functional Imaging 2017; 10137: 1013728 doi: 10.1117/12.2254383
|
17 |
Neal Bhutiani, Prejesh Philips, Charles R. Scoggins, Kelly M. McMasters, Melissa H. Potts, Robert C.G. Martin. Evaluation of tolerability and efficacy of irreversible electroporation (IRE) in treatment of Child-Pugh B (7/8) hepatocellular carcinoma (HCC). HPB 2016; 18(7): 593 doi: 10.1016/j.hpb.2016.03.609
|
18 |
Young Yun Jung, Jae‐Young Um, Gautam Sethi, Kwang Seok Ahn. Fangchinoline abrogates growth and survival of hepatocellular carcinoma by negative regulation of c‐met/HGF and its associated downstream signaling pathways. Phytotherapy Research 2022; 36(12): 4542 doi: 10.1002/ptr.7573
|
19 |
Yan‐Ping Li, Zhuo Gan, Bing Shi. Effect of body mass index on the wound infection and complications in patients with liver cancer: A meta‐analysis. International Wound Journal 2024; 21(2) doi: 10.1111/iwj.14689
|
20 |
Mirza S. Baig, Anjali Roy, Sajjan Rajpoot, Dongfang Liu, Rajkumar Savai, Sreeparna Banerjee, Manabu Kawada, Syed M. Faisal, Rohit Saluja, Uzma Saqib, Tomokazu Ohishi, Kishore K. Wary. Tumor-derived exosomes in the regulation of macrophage polarization. Inflammation Research 2020; 69(5): 435 doi: 10.1007/s00011-020-01318-0
|
21 |
Min Hee Yang, Seung Ho Baek, Jae-Young Um, Kwang Seok Ahn. Anti-neoplastic Effect of Ginkgolide C through Modulating c-Met Phosphorylation in Hepatocellular Carcinoma Cells. International Journal of Molecular Sciences 2020; 21(21): 8303 doi: 10.3390/ijms21218303
|
22 |
Gang Xu, Chengxue Dang. CMTM5 is downregulated and suppresses tumour growth in hepatocellular carcinoma through regulating PI3K-AKT signalling. Cancer Cell International 2017; 17(1) doi: 10.1186/s12935-017-0485-8
|
23 |
Li Zhang, Zongtao Chai, Siyuan Kong, Jiling Feng, Man Wu, Jiaqi Tan, Man Yuan, Gan Chen, Zhuo Li, Hua Zhou, Shuqun Cheng, Hongxi Xu. Nujiangexanthone A Inhibits Hepatocellular Carcinoma Metastasis via Down Regulation of Cofilin 1. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.644716
|
24 |
Yi Chu, Mingzuo Jiang, Feng Du, Di Chen, Tao Ye, Bing Xu, Xiaowei Li, Weijie Wang, Zhaoyan Qiu, Haiming Liu, Yongzhan Nie, Jie Liang, Daiming Fan. miR‐204‐5p suppresses hepatocellular cancer proliferation by regulating homeoprotein SIX1 expression. FEBS Open Bio 2018; 8(2): 189 doi: 10.1002/2211-5463.12363
|
25 |
Hanhan Dai, Minjing Li, Wei Yang, Xiucui Sun, Peiyuan Wang, Xia Wang, Jiaqi Su, Xu Wang, Xuemei Hu, Mingdong Zhao. Resveratrol inhibits the malignant progression of hepatocellular carcinoma via MARCH1-induced regulation of PTEN/AKT signaling. Aging 2020; 12(12): 11717 doi: 10.18632/aging.103338
|
26 |
Hong-wei Chen, A-ling Shen, Li-ya Liu, Jun Peng, Jian-feng Chu. Bear Bile Powder Inhibits Growth of Hepatocellular Carcinoma via Suppressing STAT3 Signaling Pathway in Mice. Chinese Journal of Integrative Medicine 2020; 26(5): 370 doi: 10.1007/s11655-019-3010-1
|
27 |
Atsushi Kobayashi, Toshimi Kaido, Yuhei Hamaguchi, Shinya Okumura, Hisaya Shirai, Siyuan Yao, Naoko Kamo, Shintaro Yagi, Kojiro Taura, Hideaki Okajima, Shinji Uemoto. Impact of Sarcopenic Obesity on Outcomes in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma. Annals of Surgery 2019; 269(5): 924 doi: 10.1097/SLA.0000000000002555
|
28 |
Nils Heits, Mario Brosch, Alexander Herrmann, Robin Behrens, Christoph Röcken, Harald Schrem, Alexander Kaltenborn, Jürgen Klempnauer, Hans-Heinrich Kreipe, Benedikt Reichert, Christina Lenschow, Christian Wilms, Thomas Vogel, Heiner Wolters, Eva Wardelmann, Daniel Seehofer, Stephan Buch, Sebastian Zeissig, Sven Pannach, Nathanael Raschzok, Manfred Dietel, Witigo von Schoenfels, Sebastian Hinz, Andreas Teufel, Matthias Evert, Andre Franke, Thomas Becker, Felix Braun, Jochen Hampe, Clemens Schafmayer. Evolutionary Distance Predicts Recurrence After Liver Transplantation in Multifocal Hepatocellular Carcinoma. Transplantation 2018; 102(10): e424 doi: 10.1097/TP.0000000000002356
|
29 |
Soon Kyu Lee, Myeong Jun Song, Seok Hwan Kim, Misun Park, Ming-Lung Yu. Comparing various scoring system for predicting overall survival according to treatment modalities in hepatocellular carcinoma focused on Platelet-albumin-bilirubin (PALBI) and albumin-bilirubin (ALBI) grade: A nationwide cohort study. PLOS ONE 2019; 14(5): e0216173 doi: 10.1371/journal.pone.0216173
|
30 |
Jiangsheng Huang, Jixiong Hu, Xianling Liu, Zhongkun Zuo, Tenglong Tang. Atlas of Anatomic Hepatic Resection for Hepatocellular Carcinoma. 2019; : 7 doi: 10.1007/978-981-13-0668-6_2
|
31 |
Chenxi Liu, Jie Shao, Yanbing Dong, Qiuping Xu, Zhengyun Zou, Fangjun Chen, Jing Yan, Juan Liu, Shuangshuang Li, Baorui Liu, Jie Shen. Advanced HCC Patient Benefit From Neoantigen Reactive T Cells Based Immunotherapy: A Case Report. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.685126
|
32 |
Hong Peng, Si-Yi Lei, Wei Fan, Yu Dai, Yi Zhang, Gen Chen, Ting-Ting Xiong, Tian-Zhao Liu, Yue Huang, Xiao-Feng Wang, Jin-Hui Xu, Xin-Hua Luo. Assessing recent recurrence after hepatectomy for hepatitis B-related hepatocellular carcinoma by a predictive model based on sarcopenia. World Journal of Gastroenterology 2024; 30(12): 1727-1738 doi: 10.3748/wjg.v30.i12.1727
|
33 |
Ritesh Urade, Wen-Tsan Chang, Ching-Chung Ko, Ruei-Nian Li, Hui-Min Yang, Hsuan-Yu Chen, Lin-Ya Huang, Meng-Yang Chang, Chang-Yi Wu, Chien-Chih Chiu. A fluorene derivative inhibits human hepatocellular carcinoma cells by ROS-mediated apoptosis, anoikis and autophagy. Life Sciences 2023; 329: 121835 doi: 10.1016/j.lfs.2023.121835
|
34 |
|
35 |
Da‑Ni Zhong, Yi‑Huan Luo, Wei‑Jia Mo, Xin Zhang, Zhong Tan, Na Zhao, Si‑Min Pang, Gang Chen, Min‑Hua Rong, Wei Tang. High expression of long non‑coding HOTAIR correlated with hepatocarcinogenesis and metastasis. Molecular Medicine Reports 2017; doi: 10.3892/mmr.2017.7999
|
36 |
Reina Sasaki, Tatsuo Kanda, Osamu Yokosuka, Naoya Kato, Shunichi Matsuoka, Mitsuhiko Moriyama. Exosomes and Hepatocellular Carcinoma: From Bench to Bedside. International Journal of Molecular Sciences 2019; 20(6): 1406 doi: 10.3390/ijms20061406
|
37 |
Chin-Tsung Ting, Yung-Yi Cheng, Tung-Hu Tsai. Preclinical Pharmacokinetic Interaction and Histopathological Analyses of Hedyotis diffusa on Sorafenib in Rats. ACS Omega 2021; 6(4): 3060 doi: 10.1021/acsomega.0c05461
|
38 |
Mujtaba Khalil, Diamantis I. Tsilimigras, Yutaka Endo, Muhammad Muntazir Mehdi Khan, Muhammad Musaab Munir, Erryk Katayama, Zayed Rashid, Vivian Resende, Mary Dillhoff, Jordan Cloyd, Aslam Ejaz, Timothy M. Pawlik. Association of Textbook Outcome and Hospital Volume with Long-Term Survival Following Resection for Hepatocellular Carcinoma: What Matters More?. Journal of Gastrointestinal Surgery 2023; 27(12): 2763 doi: 10.1007/s11605-023-05880-w
|